Official Publications Celyad Oncology SA

Equities

Real-time Euronext Bruxelles Other stock markets 06:50:04 2024-05-03 am EDT			5-day change	1st Jan Change
0.3105 ^EUR	+0.16%		-5.91%	-20.38%

Apr. 04	Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 09	Celyad Oncology Seeks Termination of Reporting Obligations to US SEC	MT

Mixed general shareholder meeting	Apr. 04	CO
Mixed general shareholder meeting	Apr. 04	CO
Annual results	Apr. 03	CO
Annual Report	Apr. 03	CO
Annual Report	Apr. 03	CO
Threshold crossings	Dec. 19	CO
Threshold crossings	Dec. 19	CO
Monthly statement on voting rights	Dec. 14	CO
Monthly statement on voting rights	Dec. 14	CO
Changes in management and corporate officers	Nov. 30	CO
Changes in management and corporate officers	Nov. 30	CO
Threshold crossings	Nov. 20	CO
Threshold crossings	Nov. 20	CO
Extraordinary general shareholder meeting	Nov. 20	CO
Extraordinary general shareholder meeting	Nov. 20	CO
Monthly statement on voting rights	Nov. 13	CO
Monthly statement on voting rights	Nov. 13	CO
3rd quarter results	Nov. 08	CO
Extraordinary general shareholder meeting	23-10-26	CO
Extraordinary general shareholder meeting	23-10-26	CO
Threshold crossings	23-09-11	CO
Threshold crossings	23-09-11	CO
Half-year report	23-09-03	CO
Half-year report	23-09-03	CO
Monthly statement on voting rights	23-08-30	CO